Lysophosphatidylinositol (LysoPtdIns) is formed by a constitutively-active phosphoinositide-speci®c phospholipase A 2 in Ras-transformed cells and can stimulate cell proliferation. To evaluate whether LysoPtdIns could function as an autocrine modulator of cell growth, we examined whether LysoPtdIns can be released in the medium of Ras-transformed FRT-Fibro ®broblasts and thyroid cells. Here, we report that LysoPtdIns accumulates in the extracellular space of these lines and reaches levels up to tenfold higher than in the case of normal cells. Moreover, the ionophore A23187 increased the levels of the lysolipid in the extracellular medium. Extracellular LysoPtdIns was rapidly hydrolyzed to inositol 1 : 2-cyclic phosphate. LysoPtdIns induced thymidine incorporation in FRT-Fibro Ha-Ras ®bro-blasts, whereas inositol cyclic 1 : 2-cyclic phosphate did not aect cell growth per se, nor did it interfere with the LysoPtdIns mitogenic activity. We hypothesize that in Ras-transformed ®broblasts the formation and release of LysoPtdIns may function as an autocrine mechanism that participates in the Ras-dependent stimulation of cell growth.
Introduction
Phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P 2 ) gives rise through various metabolic pathways to several intracellular messengers, the best characterized of which are 1,2-diacylglycerol and inositol-1,4,5-trisphosphate (Ins-1,4,5-P 3 ) (Berridge, 1993; Nishizuka, 1995) . Other phosphoinositide derivatives of potential biological relevance include those involved in the phosphatidylinositol 3-kinase pathway (Panayotou and Water®eld, 1992) , the inositol polyphosphates (Sasakawa et al., 1995) , the cyclic inositols (Majerus et al., 1988) , the glycerophosphoinositols (Alonso et al., 1988; Valitutti et al., 1991; Iacovelli et al., 1993; Corda and Falasca, 1996) and lysophosphatidylinositol (Falasca and Corda, 1994; Falasca et al., 1995; Metz, 1986; Baran and Kelly, 1987) .
The cellular levels of some of these phosphoinositide derivatives have been shown to be altered during Rasmediated cell transformation in a number of cell lines (Alonso et al., 1988; Valitutti et al., 1991; Corda and Falasca, 1996; Falasca and Corda, 1994; Falasca et al., 1995) . In particular, high levels of both lysophosphatidylinositol (LysoPtdIns), a molecule generated by a constitutively-active phosphoinositide (PtdIns)-speci®c phospholipase A 2 , and of glycerophosphoinositols (derived from LysoPtdIns through a second deacylation step) have been reported in cells of dierent origin transformed by the ras oncogene (Alonso et al., 1988; Valitutti et al., 1991; Iacovelli et al., 1993; Corda and Falasca, 1996; Falasca and Corda, 1994; Falasca et al., 1995) . The increase in glycerophosphoinositols and LysoPtdIns in Ras-transformed cells is most likely due to the generation of these compounds directly by enzymes participating in the Ras signaling pathway, rather than being a generic consequence of transformation, as indicated by several lines of evidence: (a) glycerophosphoinositols, the direct metabolic products of LysoPtdIns deacylation, are very rapidly and transiently increased by the activation of membrane growth-factor receptors linked to a PtdIns-speci®c phospholipase A 2 through the RasRac pathway (Falasca et al., 1997) ; (b) cell lines expressing temperature-sensitive mutants of oncogenic Ras display high levels of LysoPtdIns and glycerophosphoinositols only at the permissive temperature (Alonso and Santos, 1990; Valitutti et al., 1991; Falasca and Corda, 1994) ; (c) high glycerophosphoinositol levels are associated with Ras activation in cellular responses dierent from transformation (hepatic and neuronal dierentiation; Falasca et al., 1996; Corda and Falasca, 1996) .
In previous studies, the functional signi®cance of the agonist-dependent activation of phospholipase A 2 has been linked mainly to the production of arachidonic acid and of its active derivatives, while the role of the parallel production of LysoPtdIns reported in several systems has been overlooked (Billah and Lapetina, 1982; Hong and Dekykin, 1982; Hong et al., 1985; Lambert et al., 1986; Martin and Wysolmerski, 1986; Zoeller et al., 1987; Francel and Dawson, 1988; Bicknell and Valee, 1985; Kaya et al., 1989; Smith and Waite, 1992) . However, also LysoPtdIns and glycerophosphoinositol-4-phosphate (GroPlns-4-P) possess biological activity (Iacovelli et al., 1993; Falasca and Corda, 1994; Corda and Falasca, 1996) . Exogenously added GroPlns-4-P inhibits adenylyl cyclase, probably by acting at the level of the Gs protein (Iacovelli et al., 1993) , and a similar eect is observed when GroPlns-4-P is formed intracellularly by growth factor receptor activation (Falasca et al., 1997) . More important in the context of the Ras-induced transformation, exogenously added LysoPtdIns stimulates cell proliferation in Rastransformed thyroid cells via the activation of phospholipases C and A 2 (Falasca and Corda, 1994; Falasca et al., 1995) .
The latter observation suggests that LysoPtdIns could be a lipid mediator formed in the Ras-mediated signalling pathway and that its release into the extracellular space might provide a further mitogenic signal contributing to the Ras-induced transformation Falasca and Corda, 1994; Falasca et al., 1995) . Other lysolipids, lysophosphatidic acid (LysoPA) and lysophosphatidylcholine, have been previously shown to be mitogens (Moolenar, 1995; Falasca and Corda, 1994; Asaoka et al., 1992; Asaoka et al., 1991) acting through speci®c signaling pathways (distinct from those mediating the LysoPtdIns mitogenic signal) (Falasca and Corda, 1994) . For instance, LysoPA activates a speci®c membrane receptor coupled to G proteins and to tyrosine kinase activity (Moolenaar, 1995) . Moreover, interestingly, LysoPA can be secreted from platelets via a calcium-induced mechanism (Eichholtz et al., 1993) .
In this study we examine in a suitable cell system, the FRT ®broblast, the hypothesis that LysoPtdIns might be released into the extracellular medium by Ras-transformed cells and that it might act there as a mitogen. We ®nd that LysoPtdIns is indeed released by Ras-transformed cells and that high levels of this lysolipid are present not only intracellularly (as previously reported) but also extracellularly in Rastransformed ®broblast cultures (FRT-Fibro Ha-Ras). We also ®nd that the release of LysoPtdIns is increased by calcium in ®broblasts and thyrocytes. The extracellular LysoPtdIns is actively metabolized and its major degradation product is inositol-1 : 2-cyclic phosphate (Ins-1 : 2-cycP). Moreover, the extracellular LysoPtdIns is mitogenic to the same Ras-transformed cells that release it, suggesting that its release could play a role in the mitogenic cascade of events initiated by Ras.
Results and discussion

Phosphoinositide metabolism in FRT-Fibro and FRT-Fibro Ha-Ras cells
The Ha-Ras-transformed ®broblasts (FRT-Fibro HaRas) and the parental cells (FRT-Fibro) were chosen as a suitable system to study the Ras-dependent synthesis of LysoPtdIns. We ®rst characterized the pattern of the concentrations of LysoPtdIns, glycerophosphoinositols, and inositol phosphates in these cells. In agreement with previous observations in other lines, the levels of LysoPtdIns in FRT-Fibro Ha-Ras ®broblasts were markedly higher than in the parent FRT-Fibro cells (3 ± 10-fold, see Figure 1a ) (Falasca et al., 1995) . The accumulation of LysoPtdIns was paralleled by the increase of their water-soluble deacylation derivatives, the glycerophosphoinositols. Table   1 . The levels of glycerophosphoinositol (GroPlns), glycerophosphoinositol-4-P (GroPlns-4-P) and glycerophosphoinositol-4,5-bisphosphate (GroPlns-4,5-P 2 ) were respectively 20-, ®ve-and twofold higher in Ras-transformed cells than in the normal FRT-Fibro line.
The pattern in Figure 2b also shows that two other phosphoinositide metabolites, inositol-1-monophosphate (Ins-1-P) and inositol-2-monophosphate (Ins-2-P) were greatly increased in Ras-transformed cells. One of the possible origins of these compounds is formation via acidic hydrolysis from Ins-1 : 2-cycP, a metabolite that has been associated with cell transformation (Graham et al., 1987) . Indeed, extraction under neutral conditions (see Materials and methods) showed (Figure 2c a P50.05. nr: not resolved, i.e. the Ins-4-P peak could not be resolved from the Ins-2-P peak lel, Ins-1-P and Ins-2-P were reduced to less than 1/10 of the counts associated with these two compounds in acidic extracts (Figure 2c ). The counts associated with the inositol monophosphates in acidic extracts (Table  1) were quantitatively similar to those associated with the Ins-1 : 2-cycP obtained by neutral extraction (Table  2) . Thus, it is indeed likely that the accumulation of Ins-1-P and Ins-2-P shown in Figure 2b is in a large part due to the formation of Ins-1 : 2-cycP in Rastransformed ®broblasts, followed by its rapid hydrolysis during acidic extraction for chromatography (compare with Figure 2b and c). A quanti®cation and summary of several HPLC elution patterns of neutral extracts of normal and Ha-Ras transformed FRTFibro ®broblasts is presented in Table 2 . It appears that the levels of Ins-1 : 2-cycP were more than 100-fold higher in FRT-Fibro Ha-Ras than in normal FRTFibro cells. Thus, Ins-1 : 2-cycP was the most abundant inositol phosphate metabolite produced by FRT-Fibro Ha-Ras cells. Notably, Table 2 suggests that not all of the increase of Ins-1-P and Ins-2-P can be explained as derived from Ins-1 : 2-cycP since these two metabolites remained elevated in Ras-transformed ®broblasts even after neutral extraction (four-and 40-fold higher, respectively). Indeed, it is possible that these metabolites derive from GroPIns via enzymatic hydrolysis, as previously suggested Falasca et al., 1996 Falasca et al., , 1997 . In contrast, inositol phosphates produced by phospholipase C activation such as Ins-1,4-P 2 and Ins-1,4,5-P 3 , in agreement with previous studies, were not signi®cantly higher in Rastransformed than in normal cells (Table 1) (Alonso et al., 1988; Valitutti et al., 1991; Iacovelli et al., 1993; Corda and Falasca, 1996; Falasca and Corda, 1994) .
In summary, our study of the pattern of phosphoinositide metabolites reveals two major dierences between FRT-®bro and FRT-®bro Ha-Ras cells: the transformed line exhibits (1) higher levels of LysoPtdIns and of their water-soluble derivatives, the glycerophosphoinositols, and (2) (c) conditions. Labeling and extraction procedures were as detailed under Materials and methods. Numbers indicate the elution positions of the dierent metabolites as identi®ed by coelution with commercially available standards. 1, inositol (Ins); 2, GroPlns; 3 Ins-1 : 2-cycP; 4, Ins-1-P; 5, Ins-2-P; 6, Ins-4-P; 7, GroPlns-4-P; 8,1ns-1,4-P 2 ; 9, GroPlns-4,5-P 2 ; 10, Ins-1,3,4-P 3 ; 11, Ins-1,4,5-P 3 . Radioactivity associated with labeled compounds was analysed by an on-line¯ow detector (Packard Flo-one A-525). The inset shows a magni®ed area of the elution pattern between 50 and 90 min. The elutions shown are representative of 8 (FRT-Fibro), 9 (FRT-Fibro Ha-Ras, acidic extraction) and 5 (FRT-Fibro Ha-Ras, neutral extraction) separate experiments performed in duplicate levels of Ins-1 : 2-cycP. The possible signi®cance of the LysoPtdIns increase is discussed below. The functional role of Ins-1 : 2-cycP is unclear. Ins1 : 2-cycP is present at high levels in Morris (7777) hepatomas; this has been correlated to a decrease in the activity of the Ins-1 : 2-cycP 2-phosphohydrolase (cyclic hydrolase) (Ross and Majerus, 1992; Graham et al., 1987; . The cyclic hydrolase activity was found decreased also in src-transformed Balb-3T3 ®broblasts , and the transfection of this enzyme in NIH3T3 cells resulted in a decline in the level of Ins-1 : 2-cycP and in a parallel increase in the cell sensitivity to contact inhibition . Thus, increases in Ins-1 : 2-cycP were thought to be correlated to the loss of contact inhibition which is a characteristic of transformed ®broblasts .
Release and degradation of LysoPtdIns in FRT-Fibro Ha-Ras cells
We next proceeded to investigate whether the higher cellular concentrations of LysoPtdIns resulted in release of the lysolipid in the medium of Rastransformed ®broblasts. A precedent for release of a lysolipid mitogen is the case of LysoPA, whose secretion is stimulated by thrombin in platelets in a calcium-dependent manner (Eichholtz et al., 1993) . LysoPtdIns release was therefore studied both under control conditions and in the presence of the calcium ionophore A23187. Figure 3 shows that LysoPtdIns rapidly rose to measurable levels in the extracellular space of the ras-transformed cells and that the calcium ionophore increased the rate of release. In contrast, in normal ®broblasts the levels of extracellular Lyso PtdIns remained nearly undetectable. This raises the possibility that the release of the LysoPtdIns in the Ras-transformed line might, over long periods of time, result in a signi®cant buildup of its extracellular concentrations. Cells were labeled and the medium assayed after 48 h. At this time, the amount of LysoPtdIns in the extracellular medium of FRT-Fibro Ha-Ras cells was very signi®cant (about 20% of that present in the cells); moreover, it was more than tenfold higher than in the medium of the normal ®broblasts FRT-Fibro (Figure 1b) . In contrast, the levels of the parent lipid Ptdlns in the extracellular medium of Ras-transformed cells was only 3 ± 5% of the levels associated with cell extracts. The mechanism of LysoPtdIns release is unclear. It might be mediated by an active mechanisms, or it might be due to passive escape of a fraction of the lysolipid present at steadystate in cell membranes. After release, due to its amphipatic nature and its polar head group, LysoPtdIns is well suited to reach high concentrations in the extracellular water phase and, in vivo, in the space surrounding Ras-transformed cells. The metabolic fate and the biological activity of extracellular LysoPtdIns were therefore of interest.
Extracellular degradation of LysoPtdIns to Ins-1 : 2-cycP
An extracellular PtdIns-phospholipase C activity that hydrolyzes LysoPtdIns has been reported to be present on the cell surface of dierent cell types and also to be released by Swiss 3T3 cell cultures Pagano, 1990, 1991; Volwerk et al., 1992; Birrell et al., 1995) . In order to analyse whether such activity is also present in FRT-Fibro Ha-Ras ®broblasts, we incubated con¯uent monolayers of these cells with [ 3 H]LysoPtdIns and analysed the fate of the lysolipid. After 30 min of incubation with the radiolabeled compound, 64.5% of the radiactivity was in the extracellular medium, whereas 35.5% was found in the cells. The two pools were analysed separately. The labeled compounds in the extracellular medium were extracted and found to partition between the aqueous (45.7%) and the organic phase (18.8%). HPLC analysis after acidic or neutral extractions revealed that the only water-soluble metabolite present was Ins-1 : 2-cycP (neutral extracts) which was converted to Ins-1-P and Ins-2-P under acidic conditions. The organic phase consisted of LysoPtdIns (15.6%) and PtdIns (3.2%). In cell extracts 31.9% of the total counts were present in the organic phase and were associated with the acylation product of LysoPtdIns, PtdIns; the remaining 3.6% was present in the aqueous phase as GroPIns. In summary, of the LysoPtdIns supplied in the medium to FRT-Fibro Ras-transformed ®broblasts only 15% remains after 30 min. A large fraction of the lysolipid is metabolized in the extracellular medium to Ins-1 : 2-cycP. About a third enters the cells, where it is nearly completely reacylated to PtdIns or, to a very minor extent, hydrolyzed to GroPIns. These results, showing that the extracellular LysoPtdIns is rapidly metabolized, obviously suggest that the release rate of the lysolipid in the extracellular space is faster than one would judge from the rate of accumulation in the medium (see Figure 3) , and that accumulation represents the result of a balance between fast processes of release and degradation of the lysolipid. The rapid extracellular metabolism of LysoPtdIns to Ins-1 : 2-cycP, suggests that the latter compound might also accumulate in the culture medium of FRT-Fibro Ha-Ras cells. We directly evaluated this possibility by examining the 3 H-inositol metabolites present in the medium of these cells extracted in acidic (Figure 4a) and neutral conditions (Figure 4b ). High levels of Ins-1 : 2-cycP and of Ins-2-P were detected in the extracellular space of FRT-Fibro Ha-Ras cells (Figure 4a and Table 3 ); under acidic conditions most of the Ins-1 : 2-cycP was converted to Ins-2-P. Instead, no measurable levels of Ins-1 : 2-cycP were detected in the medium of normal FRT-Fibro ®broblasts (Table  3) . The low but measurable levels of Ins-1 : 2-cycP detected intracellularly in normal ®broblasts (Table 2) might derive from the PtdIns-speci®c phospholipase C that has been proposed to selectively lead to the formation of cyclic compounds (Dawson et al., 1971; Kim et al., 1989; Sekar et al., 1993) , rather than being related to the LysoPtdIns metabolism.
When [ 3 H]LysoPtdIns was added to the culture medium of normal ®broblasts, it appeared to be more stable than with Ras-transformed ®broblasts, in that 50% of the total lysolipid was still present in the medium after 2 ± 20 h of incubation, depending on the presence of serum (which slowed down the degradation of LysoPtdIns); moreover, no signi®cant conversion to Ins-1 : 2-cycP could be detected (Berrie and Corda, in preparation). Altogether, therefore, there are major dierences between the Ras-transformed and the control line in LysoPtdIns metabolism: the transformed cells produce, release and metabolize (to Ins-1 : 2-cycP) the lysolipid at a much faster rate that the parent line.
Eect of extracellular LysoPtdIns on [ 3 H]thymidine incorporation
Since LysoPtdIns and Ins-1 : 2-cycP are present in the extracellular medium of FRT-Fibro Ha-Ras fibroblasts, we tested whether they could both act as mitogens in these cells as well as in normal FRTFibro ®broblasts. In parallel, we examined the activity of LysoPA, a well characterized lysolipid mitogen in ®broblasts (Moolenaar, 1995) . Figure 5 shows that whereas LysoPA increased cell proliferation in both cell lines (by 3 ± 6-fold), LysoPtdIns exerted a similar eect (threefold increase) in FRT-Fibro Ha-Ras ®broblasts, but was inactive in normal FRT-Fibro cells. This is dierent from the eect we have reported in thyrocytes (Falasca and Corda, 1994; Falasca et al., 1995) , where LysoPtdIns is a mitogen both in normal and Ras-transformed cells. The dierent activity of the lysolipid might re¯ect a dierent distribution of its receptor in the dierent cell lines. Other authors have also shown that LysoPA exerts dierent actions in normal and tumor cells: for instance, whereas LysoPA is a mitogen in ®broblasts and normal epithelial cells, it becomes an inhibitor of cell proliferation in myeloma or ovarian tumor cells (Tigyi et al., 1994; Imagawa et al., 1995) or it does not aect cell growth in KiKi cells, lymphoma cells and astrocytes (Falasca and Corda, 1994; Imagawa et al., 1995) . An intriguing aspect of the ability of LysoPtdIns to stimulate thymidine incorporation is that this is a long term eect, detected several hours after the administration of the lysolipid, while LysoPtdIns is rapidly degraded in the extracellular medium. This can be explained by the fact, already demonstrated in other cases, that a transient receptor activation can be sucient to initiate long term changes in cell function. For example, in the thyroid, 70% of the eect of thyrotropin on iodide uptake or thymidine incorporation can be observed after 48 h from a 20 ± 60 min exposure of the cells to the hormone (Marcocci et al., 1983; Weiss et al., 1984) . Similarly, a brief exposure to LysoPtdIns could be sucient to cause thymidine incorporation in the in vitro assay at a later time. Under in vivo conditions these considerations might be irrelevant: as mentioned above, the LysoPtdIns release might generate and maintain concentrations of the lysolipid (which result from the balance between release and degradation) which might be sucient to sustain mitogenic activity.
Ins-1 : 2-cycP was also tested for mitogenic activity and found to be inactive in both the cell lines used in these experiments ( Figure 5 ). The possibility that Ins-1 : 2-cycP might have other biological eects was also investigated, by assaying the activities of transduction enzymes that are known to be modulated by its precursor LysoPtdIns (Falasca and Corda, 1994; Falasca et al., 1995) . LysoPtdIns inhibits the cholera toxin-stimulated cAMP levels, releases arachidonic acid and stimulates phospholipase C activity in thyroid cells (Falasca et al., 1995) . Ins-1 : 2-cycP (between 1 and 200 mM) did not aect any of these signaling pathways, nor did it interfere with the LysoPtdIns-induced modulation (data not shown). This of course does not rule out the important possibility that Ins-1 : 2-cycP might have other eects that are not revealed by our assays, such as for instance the above mentioned induction of loss of contact inhibition. Such an eect might play a critical role in vivo and our ®nding that the levels of this metabolite are enormously increased in Ras-transformed ®broblasts suggests the need for further investigation of its possible biological eects.
Mechanism of action of LysoPtdIns
A question raised by the above ®ndings is whether the mitogenic activity of LysoPtdIns might be due to the activation of a membrane receptor and whether it might be mediated by the activation of known signaling pathways. These aspects of the biology of LysoPtdIns have been previously characterized in other cell lines. LysoPtdIns has been shown to cause the activation of phospholipase C, phospholipase A 2 and tyrosine kinase (Falasca et al., 1995) . These eects are very likely to be receptor-mediated, rather than being caused by less speci®c mechanisms related to the physico-chemical properties of the lysolipid since suramin, a membrane-impermeant antagonist of several growth factor receptors including LysoPA (van Corven et al., 1992) , inhibited the LysoPtdInsdependent activation of phospholipase C, increase in cytosolic calcium and [ 3 H]thymidine incorporation (Falasca et al., 1995) . Tyrphostin AG18, a well known inhibitor of tyrosine kinases, also prevented the LysoPtdIns-dependent [ 3 H]thymidine incorporation (Falasca et al., 1995) . Some of these experiments were repeated in ®broblasts to verify that the above conclusions in other cell lines can be extended to this study. Indeed, low micromolar concentration of LysoPtdIns increased the cytosolic calcium levels (2 ± 3-fold), and the calcium rise was readily reverted upon wash-out of the lysolipid, indicating that LysoPtdIns induces a receptor-mediated activation of phospholipase C also in this system, in agreement with the data previously reported in epithelial cells. The possibility that LysoPtdIns could activate phosphatidylinositol 3-kinase (not previously tested in other cell lines) was then examined (by HPLC detection of the phosphatidylinositol 3-phosphates levels). The levels of phosphatidylinositol 3-phosphates were not aected by LysoPtdIns, whereas in parallel experiments, EGF induced the expected stimulation of this enzyme (not shown). These data suggest that the phosphatidylino- 3 H]thymidine incorporation was assayed as described in Materials and methods. Values represent the mean+s.e. of three to four experiments performed in triplicate sitol 3-kinase is not part of the mitogenic signal initiated by LysoPtdIns. While it is clear that LysoPtdIns activates known signaling pathways in several cell lines, the determination of the links between these signals and the lysolipid's mitogenic activity requires further work.
Generality of the release of LysoPtdIns in Ras-transformed cells
We next wanted to examine whether the Rasdependent release of LysoPtdIns was restricted to rat ®broblasts or might be a more general phenomenon. We have previously reported that Ras-transformed thyroid cells (KiKi) have high levels of LysoPtdIns and GroPIns (Valitutti et al., 1991; Iacovelli et al., 1993; Corda and Falasca, 1996; Falasca and Corda, 1994; Falasca et al., 1995) . Similar to the observations made with FRT-®broblasts, LysoPtdIns was present intracellularly and in the extracellular medium of Rastransformed thyroid cells (82+39 c.p.m. in the medium and 357+30 c.p.m. in the cells, by t.l.c. analysis, see Materials and methods), whereas it was undetectable in the extracellular medium of dierentiated FRTL5 thyroid cells. Moreover, in these cells, like in rat FRT-®broblasts, the calcium ionophore A23187 caused the release of LysoPtdIns in the extracellular medium. Thus, LysoPtdIns release might be a widespread phenomenon occurring when the lysolipid is formed intracellularly either following a direct stimulation of phospholipase A 2 (by calcium or activated receptors) or by the Ras-dependent activation of the enzyme Falasca et al., 1996 Falasca et al., , 1997 .
Conclusions
Lysolipids are rapidly metabolized to glycerophospholipids or reacylated to phospholipids. This is an important event in the homeostasis of the cell, since high concentrations of lysolipid might be lytic to the membrane (Weiltzien, 1979) . Possibly for this reason, lysolipids have been considered for a long time just as intermediates of the membrane phospholipid remodeling process (Weiltzien, 1979) , and their possible role as active cell regulators has been overlooked. Several laboratories including ours, however, have recently shown that certain lysolipids possess potent biological activities. This was ®rst demonstrated for the mitogen LysoPA (Moolenaar, 1995) and then extended to lysophosphatidylcholine and LysoPtdIns (Asaoka et al., 1991 (Asaoka et al., , 1992 Falasca and Corda, 1994; Falasca et al., 1995; Metz, 1986) .
The central ®ndings of this study are (1) LysoPtdIns is formed and released by Ras-transformed ®broblasts and thyrocytes much more rapidly than by their nontransformed counterparts, (2) extracellular LysoPtdIns is rapidly metabolized to Ins-1 : 2-cycP, which reaches enormously high levels in the medium of transformed cells, and (3) LysoPtdIns can be mitogenic to the same transformed cells that generate it. While the significance of these observations for in vivo tumors remains a question for future work, our data indicate that the release of LysoPtdIns, with time, in spite of active extracellular metabolism, can result in a very signi®cant build-up of the lysolipid in the extracellular medium.
An even more massive build-up in vivo could be expected for Ins-1 : 2-cycP. Since in an organ the interstitial space is a small fraction of the total volume, it is conceivable that the release we have described under in vitro culture conditions might, in vivo, rapidly result in levels of LysoPtdIns that could exert mitogenic activity. As for Ins-1 : 2-cycP, as mentioned before, its biological activity is unclear, although a role in inducing loss of contact inhibition in cancer cells has been hypothesized . The observation that the generation of Ins-1 : 2-cycP is greatly increased in Ras-transformed ®broblasts is intriguing, and points to a possible signi®cance of this molecule in transformation. Further work is needed to clarify this question.
In conclusion, based on the above collective results, it can be hypothesized that LysoPtdIns, and perhaps Ins-1 : 2-cycP may function as a mediator(s) in an autocrine loop promoting growth in Ras-transformed cells, a process that would add a stimulatory input to the eect of the classical Ras cascade. The mitogenic activity of LysoPtdIns has been proposed to be mediated by a speci®c receptor on the plasma membrane (Falasca and Corda, 1994; Falasca et al., 1995) , hence accessible to exogenous ligands. If the production and release of LysoPtdIns are signi®cant factors in the growth of Ras-dependent tumors, the development of antagonists at the LysoPtdIns receptor might provide tools to limit the growth of such tumors.
Materials and methods
Materials
Hormones used in the tissue culture media and Coon's modi®ed Ham's F12 medium were obtained from Sigma (St Louis, MO). Tissue culture materials were from Gibco (Grand Island, NY, USA). [
3 H]Inositol and its phosphate derivatives used as standards and [ 3 H]thymidine were obtained from New England Nuclear (Boston, MA, USA). All chemicals were obtained from commercial sources as the highest purity material available.
Cell cultures
FRT-Fibro and FRT-Fibro Ha-Ras cells, a cell line derived from rat thyroid ®broblasts, were grown in Coon's modi®ed Ham F-12 medium supplemented with 5% (vol/ vol) calf serum, 20 mM glutamine, 100 mg ml 71 streptomycin, 10 mg ml 71 gentamycin and 100 units/ml penicillin at 378C in a humidi®ed atmosphere of 5% CO 2 -95% air (Fusco et al., 1987; Chiariotti et al., 1992) . FRTL5 are dierentiated thyroid cells, that were maintained as described (Ambesi-Impiombato and Perrild, 1989; Ambesi-Impiombato et al., 1980; Valente et al., 1983) . Brie¯y, the cells were grown in Coon's modi®ed Ham F-12 medium supplemented with 5% (vol/vol) calf serum, 20 mM glutamine and a mixture of six hormones (thyrotropin, insulin, cortisol, transferrin, somatostatin, 1-glycyl-Lhistidyl-L-lysine acetate) at 378C in a humidi®ed atmosphere of 5% CO 2 -95% air. KiKi cells are derived from FRTL5 cells infected by kiMSV-KiMuLV. These cells express high levels of Ras-p21, lose thyroid dierentiated functions and grow in a hormone-independent manner; they were routinely cultured in the same medium as the FRTL5 cells, deprived of the hormone mixture (Fusco et al., 1981 (Fusco et al., , 1982 Colletta et al., 1983 ).
Analysis of [ 3 H]inositol phospholipids
For inositol phospholipid evaluation, cells grown in 12 well plates were labeled for 48 h in Medium 199 containing [ 3 H]myo-inositol (5 mCi/ml) and 2% calf serum as previously reported (Iacovelli et al., 1993; Falasca and Corda, 1994; Falasca et al., 1995) . Following the incubation with radiolabeled [ 3 H]inositol, cells were washed once with Hank's Balanced Salt Solution (HBSS) and then extracted with methanol/chloroform/water/HCl (12 N) (1 : 1 : 0.5 : 0.01) and the aqueous and organic phases were separated by centrifugation at 600 g for 10 min. The aqueous phase was lyophilized and stored at 7808C.
Neutral extraction was performed as reported above with only the omission of HCI (12 N). For acid medium extaction, ®rst cell debris were removed by centrifugation at 8000 g for 5 min, then 2 ml of methanol/chloroform (1 : 1) and 10 ml of HCI (12 N) were added to 0.5 ml of medium.
Butanol extraction of medium was performed by adding acetic acid (0.02 M) and extracting with 0.5 vol of butanol-1-ol (Kolarovic and Fournier, 1986) . The two-phase system was frozen after thorough mixing and thawed again in order to improve the separation of the two phases. After centrifugation, the butanol-1-ol phase was removed and the water phase was extracted once again. Butanol fractions were collected, washed, dried under nitrogen and analysed as described above.
The organic phase was analysed by thin layer chromatography (t.l.c.) using silica gel-G plates (Kieselgel 60 F 254 , Merck) as previously described (Falasca and Corda, 1994) . The dierent phospholipids were identi®ed by comigration with unlabeled standards (visualized by exposure to iodine vapour). The R f values were as follows: 0.18, phosphatidylinositol-4,5-bisphosphate; 0.50, phosphatidylinositol-4-phosphate; 0.60, LysoPtdIns and 0.69, phosphatidylinositol. The radioactivity associated with the dierent lipids was evaluated by gas ionization scanning using a linear analyser INB 384 (Inotech, Switzerland). Counting eciency was *2%. Counts were collected until a counting error 52% was obtained. Each t.l.c. plate was usually counted for 30 min. The total radioactivity associated with the cell extract was evaluated by both liquid scintillation and gas ionization counting.
Measurement of [ 3 H]inositol phosphates by HPLC
The water-soluble [ 3 H]inositol containing metabolites were separated by HPLC analysis (Iacovelli et al., 1993; Falasca et al., 1996) . Aliquots of the aqueous phase were dissolved in 1 ml of water and applied to a column of Partisil 10 SAX (4.6 mm625 cm; Whatman); the column was washed with water and a non-linear gradient of ammonium phosphate 0 ± 1 M (pH 3.35) was applied (Iacovelli et al., 1993; Falasca et al., 1996) . The elution was as follows: H 2 O at 1 ml/min¯ow for the ®rst 5 min, followed by a linear gradient of 0 ± 30 mM ammonium phosphate (5 ± 55 min) to resolve GroPlns and InsPs separation, then a gradient of 30 mM ± 1 M (55 ± 115 min) for the separation of other inositol derivatives. Radioactivity in the eluate was monitored with an on-line radioactivity¯ow detector (Packard FLO ONE A-525). Commercial [ 3 H]standards (Du Pont-New England Nuclear) included inositol 1-monophosphate (Ins-1-P), inositol 4-monophosphate (Ins-4-P), inositol 1,4-bisphosphate (Ins-1,4-P 2 ), inositol 1,3,4-trisphosphate (Ins-1,3,4-P 3 ), inositol 1,4,5-trisphosphate (Ins-1,4,5-P 3 ), and inositol 1,3,4,5-tetraphosphate (Ins-1,3,4,5-P 4 ). Alkaline hydrolysis in monomethylamine of inositol-labeled phosphoinositide standards was used to produce the corresponding glycerophosphoinositols (GroPlns, GroPlns-4-P, and GroPlns-4,5-P 2 ) as described (Iacovelli et al., 1993) . The Ins-1 : 2-cycP was produced as described .
Ecto-phospholipase C activity assay
LysoPtdIns-speci®c phospholipase C activity was determined by measuring the production of radioactive inositol monophosphates from [ 3 H]LysoPtdIns as substrate. The standard assay mixture for measuring ecto-phospholipase C activity contained [ 3 H]LysoPtdIns (30 000 c.p.m./well), in HBSS buer containing 10 mM HEPES and 10 mM LiCl. Incubations with [
3 H]LysoPtdIns were performed in 12 well plates in a total volume of 0.5 ml at 378C, and were stopped by removing the medium. Both medium and cells were extracted as reported above and the radioactivity associated with the dierent compounds was determined as described. 3 H]thymidine incorporation as described (Falasca et al., 1995) . Brie¯y, FRT-Fibro and FRT-Fibro Ha-Ras cells were seeded in 96 well plates in growth medium. After 24 h cells were re-fed with culture medium with 1% serum. After a 48 h starvation, stimulants were added for 18 h, the pulse of [ 3 H]thymidine (0.25 mCi per well) was for the last 3 h. The [ 3 H]thymidine incorporated into trichloroacetic acid-insoluble material was evaluated as previously described (Falasca et al., 1995) .
Statistical analysis
All experiment are presented as the average of duplicate or triplicate determinations repeated at least three times. Statistical analysis was carried out by Student's t-test.
